• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group.

作者信息

Gerhartz H H, Visani G, Delmer A, Zwierzina H, Ribeiro M, Jacobs A, Marcus R, Baumelou M, Fière D, Labar B

机构信息

Med. Dept. III, Klinikum Grosshadern, Munich University, FRG.

出版信息

Bone Marrow Transplant. 1989 Dec;4 Suppl 3:36-7.

PMID:2697397
Abstract
摘要

相似文献

1
Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group.小剂量阿糖胞苷联合粒细胞/巨噬细胞集落刺激因子治疗骨髓增生异常综合征。欧洲癌症研究与治疗组织白血病小组。
Bone Marrow Transplant. 1989 Dec;4 Suppl 3:36-7.
2
Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study.重组人粒细胞-巨噬细胞集落刺激因子与小剂量阿糖胞苷治疗骨髓增生异常综合征患者：一项II期研究
Onkologie. 1990 Feb;13(1):33-7. doi: 10.1159/000216716.
3
Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine arabinoside in patients with myelodysplastic syndrome. A pilot study.重组人粒细胞-巨噬细胞集落刺激因子与小剂量阿糖胞苷治疗骨髓增生异常综合征患者：一项初步研究。
Onkologie. 1989 Feb;12(1):13-5. doi: 10.1159/000216589.
4
Treatment with cytosine arabinoside and granulocyte colony-stimulating factor in patients with myelodysplastic syndrome and its leukemic phase.阿糖胞苷与粒细胞集落刺激因子治疗骨髓增生异常综合征及其白血病期患者。
Int J Hematol. 1994 Oct;60(3):215-23.
5
Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.对于单独使用促红细胞生成素无反应的输血依赖型骨髓增生异常综合征患者，在促红细胞生成素中添加生长因子或白细胞介素-3对贫血的治疗效果有限。
Haematologica. 2001 Jan;86(1):44-51.
6
[Management of myelodysplastic syndromes].[骨髓增生异常综合征的管理]
Rinsho Ketsueki. 1990 Apr;31(4):416-30.
7
[Recent progress in the treatment of hematological malignancies. III. Management of patients with myelodysplastic syndromes and atypical leukemias].[血液系统恶性肿瘤治疗的最新进展。III. 骨髓增生异常综合征和非典型白血病患者的管理]
Nihon Naika Gakkai Zasshi. 1989 Jun;78(6):785-8.
8
Granulocyte-macrophage colony-stimulating factor and myelodysplastic syndromes.粒细胞-巨噬细胞集落刺激因子与骨髓增生异常综合征
N Engl J Med. 1988 Jul 7;319(1):51-3. doi: 10.1056/NEJM198807073190112.
9
[In vitro growth and clinical response of leukemia cells to macrophage colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor (G-CSF) in acute leukemia].[急性白血病中白血病细胞对巨噬细胞集落刺激因子（M-CSF）和粒细胞集落刺激因子（G-CSF）的体外生长及临床反应]
Gan To Kagaku Ryoho. 2000 Jun;27(6):873-8.
10
Phase I/II study with GM-CSF in patients with myelodysplastic syndromes.
Behring Inst Mitt. 1988 Aug(83):134-8.

引用本文的文献

1
Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.重组粒细胞-巨噬细胞集落刺激因子（rGM-CSF）：其药理特性及在骨髓抑制管理中的潜在作用综述
Drugs. 1992 Apr;43(4):516-560. doi: 10.2165/00003495-199243040-00008.
2
Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes.粒细胞和粒细胞巨噬细胞集落刺激因子用于新诊断的骨髓增生异常综合征患者。
Cochrane Database Syst Rev. 2016 Feb 16;2(2):CD009310. doi: 10.1002/14651858.CD009310.pub2.
3
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
成人原发性骨髓增生异常综合征的诊断和治疗：欧洲白血病网络的建议。
Blood. 2013 Oct 24;122(17):2943-64. doi: 10.1182/blood-2013-03-492884. Epub 2013 Aug 26.
4
Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly? A report on 77 cases.低剂量阿糖胞苷在老年初治急性髓系白血病中仍有作用吗？77例报告。
Ann Hematol. 1993 May;66(5):235-40. doi: 10.1007/BF01738471.
5
Regulation of granulocytosis in inflammatory disease and in leukemia.
Med Oncol Tumor Pharmacother. 1993;10(1-2):1-3. doi: 10.1007/BF02987761.